Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   syndrome of inappropriate antidiuretic hormone
  

Disease ID 1309
Disease syndrome of inappropriate antidiuretic hormone
Definition
A condition of HYPONATREMIA and renal salt loss attributed to overexpansion of BODY FLUIDS resulting from sustained release of ANTIDIURETIC HORMONES which stimulates renal resorption of water. It is characterized by normal KIDNEY function, high urine OSMOLALITY, low serum osmolality, and neurological dysfunction. Etiologies include ADH-producing neoplasms, injuries or diseases involving the HYPOTHALAMUS, the PITUITARY GLAND, and the LUNG. This syndrome can also be drug-induced.
Synonym
adh inappropriate
adh inappropriate secretion
adh inappropriate syndrome
adh inappropriate syndromes
adh syndrome, inappropriate
antidiuretic hormone inappropriate secret
antidiuretic hormone inappropriate secretion syndrome
antidiuretic hormone inappropriate secretion syndrome siadh
antidiuretic hormone, inappropriate secretion
inappropriate adh
inappropriate adh secretion
inappropriate adh syndrome
inappropriate adh syndrome [disease/finding]
inappropriate antidiuretic hormone secretion syndrome
inappropriate secretion of antidiuretic hormone
inappropriate vasopressin secret syndrome
inappropriate vasopressin secretion syndrome
schwartz bartter syndrome
schwartz-bartter syndrome
schwarz-bartter syndrome
siad - syndrome of inappropriate antidiuresis
siadh
siadh - syndrome of inappropriate secretion of antidiuretic hormone
siadhs
syndrome inappropriate adh
syndrome inappropriate adh siadh secret
syndrome of inappropriate adh (siadh) secretion
syndrome of inappropriate adh production
syndrome of inappropriate antidiuresis
syndrome of inappropriate antidiuretic hormone (siadh)
syndrome of inappropriate antidiuretic hormone secretion
syndrome of inappropriate secretion of adh
syndrome of inappropriate secretion of antidiuretic hormone
syndrome of inappropriate secretion of antidiuretic hormone (disorder)
syndrome of inappropriate vasopressin secretion
syndrome of inappropriate vasopressin secretion (disorder)
syndrome, inappropriate adh
syndrome, schwartz-bartter
DOID
ICD10
UMLS
C0021141
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:40)
C0011847  |  diabetes  |  2
C0011848  |  diabetes insipidus  |  2
C0023890  |  cirrhosis  |  2
C0206717  |  olfactory neuroblastoma  |  2
C0025202  |  melanoma  |  1
C0012739  |  disseminated intravascular coagulation  |  1
C0278701  |  gastric adenocarcinoma  |  1
C0026764  |  plasma cell myeloma  |  1
C0027873  |  neuromyelitis optica  |  1
C1834580  |  ramsay hunt syndrome  |  1
C0025202  |  malignant melanoma  |  1
C0206754  |  neuroendocrine tumor  |  1
C0041296  |  tuberculosis  |  1
C0041327  |  pulmonary tuberculosis  |  1
C1140680  |  ovarian cancer  |  1
C0027819  |  neuroblastoma  |  1
C0376358  |  prostate cancer  |  1
C0025289  |  meningitis  |  1
C0001623  |  adrenal insufficiency  |  1
C0020676  |  hypothyroidism  |  1
C0018378  |  guillain-barre syndrome  |  1
C0023890  |  liver cirrhosis  |  1
C0024115  |  pulmonary disease  |  1
C0149925  |  small cell carcinoma  |  1
C0085253  |  adult still's disease  |  1
C1140680  |  ovarian ca  |  1
C0023895  |  liver disease  |  1
C0023493  |  adult t-cell leukaemia/lymphoma  |  1
C0242379  |  lung cancer  |  1
C0019099  |  crimean-congo hemorrhagic fever  |  1
C0235660  |  galactorrhea  |  1
C0302592  |  carcinoma of the uterine cervix  |  1
C0162429  |  malnutrition  |  1
C0278883  |  metastatic melanoma  |  1
C0022972  |  myasthenic syndrome  |  1
C1565489  |  renal insufficiency  |  1
C0023493  |  adult t-cell leukaemia  |  1
C0010481  |  cushing's syndrome  |  1
C0001418  |  adenocarcinoma  |  1
C0149925  |  small cell lung cancer  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:1)
AVP  |  551  |  CTD_human
Inferring Gene(Waiting for update.)
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:46)
359  |  AQP2  |  DISEASES
5020  |  OXT  |  DISEASES
343  |  AQP8  |  DISEASES
2026  |  ENO2  |  DISEASES
6615  |  SNAI1  |  DISEASES
6568  |  SLC17A1  |  DISEASES
1264  |  CNN1  |  DISEASES
3569  |  IL6  |  DISEASES
109  |  ADCY3  |  DISEASES
23476  |  BRD4  |  DISEASES
5775  |  PTPN4  |  DISEASES
1371  |  CPOX  |  DISEASES
5443  |  POMC  |  DISEASES
56606  |  SLC2A9  |  DISEASES
5972  |  REN  |  DISEASES
10699  |  CORIN  |  DISEASES
1392  |  CRH  |  DISEASES
3060  |  HCRT  |  DISEASES
213  |  ALB  |  DISEASES
364  |  AQP7  |  DISEASES
360  |  AQP3  |  DISEASES
717  |  C2  |  DISEASES
7846  |  TUBA1A  |  DISEASES
5368  |  PNOC  |  DISEASES
5729  |  PTGDR  |  DISEASES
29984  |  RHOD  |  DISEASES
358  |  AQP1  |  DISEASES
196500  |  PIANP  |  DISEASES
363  |  AQP6  |  DISEASES
113457  |  TUBA3D  |  DISEASES
9622  |  KLK4  |  DISEASES
554  |  AVPR2  |  DISEASES
113675  |  SDSL  |  DISEASES
26047  |  CNTNAP2  |  DISEASES
959  |  CD40LG  |  DISEASES
9211  |  LGI1  |  DISEASES
116085  |  SLC22A12  |  DISEASES
551  |  AVP  |  DISEASES
6557  |  SLC12A1  |  DISEASES
26278  |  SACS  |  DISEASES
361  |  AQP4  |  DISEASES
11202  |  KLK8  |  DISEASES
210  |  ALAD  |  DISEASES
6628  |  SNRPB  |  DISEASES
3077  |  HFE  |  DISEASES
111  |  ADCY5  |  DISEASES
Locus(Waiting for update.)
Disease ID 1309
Disease syndrome of inappropriate antidiuretic hormone
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:20)
HP:0002902  |  Hyponatremia  |  21
HP:0000873  |  Diabetes insipidus  |  2
HP:0001394  |  Hepatic cirrhosis  |  2
HP:0002861  |  Melanoma  |  2
HP:0001250  |  Seizures  |  1
HP:0000846  |  Hypoadrenalism  |  1
HP:0000083  |  Renal insufficiency  |  1
HP:0030731  |  Carcinoma  |  1
HP:0012125  |  Prostate cancer  |  1
HP:0030357  |  Small cell lung carcinoma  |  1
HP:0005521  |  Disseminated intravascular coagulation  |  1
HP:0002664  |  Neoplasia  |  1
HP:0100829  |  Galactorrhoea  |  1
HP:0003228  |  High blood sodium levels  |  1
HP:0003256  |  Coagulopathy  |  1
HP:0002948  |  Fusion of vertebral bodies  |  1
HP:0000821  |  Underactive thyroid  |  1
HP:0010934  |  Increased urinary xanthine  |  1
HP:0004395  |  Malnutrition  |  1
HP:0001287  |  Meningitis  |  1
Disease ID 1309
Disease syndrome of inappropriate antidiuretic hormone
Manually Symptom(Waiting for update.)
Text Mined Symptom(Waiting for update.)
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:0)
(Waiting for update.)
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Chemical(Total Drugs:38)
CUI ChemicalName ChemicalID CasRN DiseaseName DiseaseID DirectEvidence PubMedIDs
C0021141aminoglutethimideD000616125-84-8inappropriate adh syndromeMESH:D007177marker/mechanism3801835
C0021141amitriptylineD00063950-48-6inappropriate adh syndromeMESH:D007177marker/mechanism20672238
C0021141aripiprazoleD000068180-inappropriate adh syndromeMESH:D007177marker/mechanism16858173
C0021141azithromycinD01796383905-01-5inappropriate adh syndromeMESH:D007177marker/mechanism9391684
C0021141carbamazepineD002220298-46-4inappropriate adh syndromeMESH:D007177marker/mechanism10024990
C0021141chlorambucilD002699305-03-3inappropriate adh syndromeMESH:D007177marker/mechanism10037268
C0021141chlorpromazineD00274650-53-3inappropriate adh syndromeMESH:D007177marker/mechanism6640486
C0021141citalopramD01528359729-33-8inappropriate adh syndromeMESH:D007177marker/mechanism12075041
C0021141clonidineD0030004205-90-7inappropriate adh syndromeMESH:D007177marker/mechanism432171
C0021141cyclophosphamideD00352050-18-0inappropriate adh syndromeMESH:D007177marker/mechanism18988633
C0021141cisplatinD00294515663-27-1inappropriate adh syndromeMESH:D007177marker/mechanism15675594
C0021141diclofenacD00400815307-86-5inappropriate adh syndromeMESH:D007177marker/mechanism8443484
C0021141enalaprilD00465675847-73-3inappropriate adh syndromeMESH:D007177marker/mechanism12087354
C0021141ethionamideD005000536-33-4inappropriate adh syndromeMESH:D007177marker/mechanism17240918
C0021141fluorouracilD00547251-21-8inappropriate adh syndromeMESH:D007177marker/mechanism20841948
C0021141fluoxetineD00547354910-89-3inappropriate adh syndromeMESH:D007177marker/mechanism16622573
C0021141fluvoxamineD01666654739-18-3inappropriate adh syndromeMESH:D007177marker/mechanism11195401
C0021141haloperidolD00622052-86-8inappropriate adh syndromeMESH:D007177marker/mechanism16999280
C0021141ifosfamideD0070693778-73-2inappropriate adh syndromeMESH:D007177marker/mechanism19542534
C0021141imipramineD00709950-49-7inappropriate adh syndromeMESH:D007177marker/mechanism1448636
C0021141indomethacinD00721353-86-1inappropriate adh syndromeMESH:D007177marker/mechanism1871284
C0021141lorazepamD008140846-49-1inappropriate adh syndromeMESH:D007177marker/mechanism3140958
C0021141melphalanD008558148-82-3inappropriate adh syndromeMESH:D007177marker/mechanism3965085
C0021141methotrexateD0087271959/5/2inappropriate adh syndromeMESH:D007177marker/mechanism20470218
C0021141phenytoinD01067257-41-0inappropriate adh syndromeMESH:D007177marker/mechanism1733741
C0021141phenytoinD01067257-41-0inappropriate adh syndromeMESH:D007177therapeutic11948390
C0021141pramipexoleC061333-inappropriate adh syndromeMESH:D007177marker/mechanism16130408
C0021141prochlorperazineD01134658-38-8inappropriate adh syndromeMESH:D007177marker/mechanism7627260
C0021141rifabutinD01782872559-06-9inappropriate adh syndromeMESH:D007177marker/mechanism11310523
C0021141tacrolimusD016559109581-93-3inappropriate adh syndromeMESH:D007177marker/mechanism14604289
C0021141theophyllineD01380658-55-9inappropriate adh syndromeMESH:D007177marker/mechanism12086552
C0021141thiotepaD01385252-24-4inappropriate adh syndromeMESH:D007177marker/mechanism10482945
C0021141trihexyphenidylD014282144-11-6inappropriate adh syndromeMESH:D007177marker/mechanism9452348
C0021141valproic acidD01463599-66-1inappropriate adh syndromeMESH:D007177marker/mechanism11195262
C0021141vinblastineD014747865-21-4inappropriate adh syndromeMESH:D007177marker/mechanism3686684
C0021141vincristineD014750-inappropriate adh syndromeMESH:D007177marker/mechanism10660739
C0021141vindesineD01475153643-48-4inappropriate adh syndromeMESH:D007177marker/mechanism2053780
C0021141vinorelbineC03085271486-22-1inappropriate adh syndromeMESH:D007177marker/mechanism17848819
FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)
FDA labeling changes(Total Drugs:0)
(Waiting for update.)